Search results
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
NBC Washington· 1 day agoFederal regulators are challenging patents on 20 brand name drugs, including the blockbuster...
FTC targets ‘junk patents’ on Ozempic, other top drugs
BioPharma Dive via Yahoo Finance· 15 hours agoThe move broadens the antitrust regulator’s campaign against allegedly “improper or inaccurate” ...
Vision Marine files patent for electric boat cooling system By Investing.com
Investing.com· 8 hours agoVision Marine Technologies Inc. (NASDAQ:VMAR), a key player in electric marine propulsion, has filed...
Altamira Therapeutics files new RNA delivery patent By Investing.com
Investing.com· 12 hours agoAltamira Therapeutics Ltd. (NASDAQ:CYTO), a biopharmaceutical company focusing on RNA delivery...
FTC Targets ‘Junk’ Patent Listings on Ozempic and Other Drugs
The Wall Street Journal· 1 day agoHEALTH NEWS The Federal Trade Commission is challenging hundreds of pharmaceutical patent listings...
Drugmakers Exposed to Antitrust Probes if Patent Cache Adopted
Bloomberg Law· 17 hours agoA proposed patent office depository for sealed settlements could expose pharmaceutical giants to antitrust scrutiny if investigators use it to identify which companies may ...
UCB, Inc. v. Mylan Techs. Inc. - Neupro® (Rotigotine) | JD Supra
JD Supra· 58 minutes agoNature of the Case and Issue(s) Presented: Neupro is a transdermal patch indicated for the treatment of Parkinson’s’ disease and restless leg syndrome. On March 24, 2017, UCB filed a complaint ...
FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempic
CNBC· 1 day agoThe Federal Trade Commission on Tuesday said it is challenging hundreds of alleged "junk" patents...